Fridays vs Noom Med (2026): prices, structure, verdict

On tirzepatide, only Fridays has a rankable figure: $359 a month all-in; Noom Med↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Fridays is cheaper: $175 versus $199 a month all-in — a $24 monthly gap, $288 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Fridays: the record, condensed

On tirzepatide, the number that matters at Fridays is $359 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $359 is the whole subscription, which makes Fridays unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #13 of 17 in the verified tirzepatide index — $144/month above the floor (NexLife↗, $215) — and sits $90 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $4,308.

Fridays’s semaglutide program bills $175 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $175 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #7 of 20 verified programs, with the floor $42/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $174 a month. A year at this figure: $2,100 monthly-billed.

Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗

Noom Med: the record, condensed

On semaglutide, the number that matters at Noom Med is $199 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #12 of 20 verified programs, with the floor $66/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $150 a month. A year at this figure: $2,388 monthly-billed.

Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗

Semaglutide: the duel in full

Put the two semaglutide figures side by side and hold them there: Fridays at $175, Noom Med at $199 — a $24 monthly spread that compounds to $288 over a maintenance year and $576 over two.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $24 gap is exactly what it appears to be.

Translate the $24/month spread into medication: $288 a year equals roughly 1.6 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.

On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: Fridays $175/mo month-to-month versus Noom Med $199/mo month-to-month. Same winner on both bases — Fridays leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Fridays $525 monthly; Noom Med $597 monthly — best path favors Fridays by $72. 6 months: Fridays $1,050 monthly; Noom Med $1,194 monthly — best path favors Fridays by $144. 12 months: Fridays $2,100 monthly; Noom Med $2,388 monthly — best path favors Fridays by $288. 24 months: Fridays $4,200 monthly; Noom Med $4,776 monthly — best path favors Fridays by $576.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Fridays publishes “not published”; Noom Med publishes “most states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Noom Med names its network (Tailor Made Compounding (named)); Fridays does not, which shifts the burden of verification onto your intake questions.

Exit terms: Fridays — annual plan for lowest rate; not published. Noom Med — 12-week cycles; 12-week billing cycles.

Evidence: Fridays third-party reported (captured 2026-08-05); Noom Med source-verified (2026-08-08).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

In the full semaglutide index these two sit at #7 and #12 of 20: between them lie 4 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Fridays and Noom Med

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Fridays: not published; Noom Med: 12-week billing cycles) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings